TSC2 and lymphangioleiomyomatosis: AdPLA2 expression was higher by 3.5-fold in TSC2-deficient LAM patient-derived cells (TSC2−) compared with TSC2-addback cells (TSC2+) (p<0.001, Figure 3A).